(Q24276196)

Europe PubMed Central

PubMed publication ID

20890797

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20890797

25 July 2024

main subject

Guillain–Barré syndrome

0 references

5

Yehuda Shoenfeld

0 references

Miri Blank

3

Miri Blank

0 references

Nancy Agmon-Levin

2

Nancy Agmon-Levin

0 references

Joab Chapman

4

Joab Chapman

0 references

Eitan Israeli

1

Eitan Israeli

0 references

language of work or name

English

0 references

publication date

5 October 2010

0 references

April 2012

1 reference

National Center for Biotechnology Information

PubMed publication ID

20890797

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20890797

full work available at URL

25 July 2024

https://link.springer.com/content/pdf/10.1007%2Fs12016-010-8213-3.pdf

file format

Portable Document Format

online access status

open access

1 reference

Europe PubMed Central

PubMed publication ID

20890797

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20890797

http://link.springer.com/content/pdf/10.1007/s12016-010-8213-3.pdf

25 July 2024

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S12016-010-8213-3

http://link.springer.com/article/10.1007/s12016-010-8213-3/fulltext.html

25 July 2024

1 reference

https://api.crossref.org/works/10.1007/S12016-010-8213-3

http://link.springer.com/content/pdf/10.1007/s12016-010-8213-3

25 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S12016-010-8213-3

Clinical Reviews in Allergy & Immunology

25 July 2024

published in

0 references

volume

42

0 references

issue

2

0 references

page(s)

121-130

0 references

cites work

Guillain-Barré syndrome: an update

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Defining criteria for autoimmune diseases (Witebsky's postulates revisited)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré as an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

The immunobiology of Guillain-Barré syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

ROLE OF INFECTION IN THE GUILLAIN-BARR'E SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré Syndrome after Chikungunya Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome following hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Infections and autoimmunity--friends or foes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome after combined tetanus-diphtheria toxoid vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

A prospective study of acute idiopathic neuropathy. II. Antecedent events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Recurrent Guillain-Barré syndrome following influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Relapsing neuropathy due to tetanus toxoid. Report of a case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Clustering sodium channels at the node of Ranvier: close encounters of the axon-glia kind

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Molecular mimicry in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Evidence for the use of intravenous immunoglobulins--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Autoimmunity: from the mosaic to the kaleidoscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Vaccination and autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Infections as triggers and complications of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Human parvovirus B19 infection and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Chronic fatigue syndrome with autoantibodies--the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Infectious associations of Celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Aberrant Epstein-Barr viral infection in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

What is the contents of the magic draft IVIg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Autoimmune response following annual influenza vaccination in 92 apparently healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome following administration of live measles vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Possible association of Guillain-Barré syndrome and hepatitis A vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Influenza vaccination and Guillain Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré syndrome following influenza vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Autoimmunity and persistent viral infection: Two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré Syndrome After Influenza Vaccination in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

Guillain-Barré Syndrome in Recipients of A/New Jersey Influenza Vaccine

21 January 2018

1 reference

12 December 2020

Comprehensive Analysis of Bacterial Risk Factors for the Development of Guillain‐Barré Syndrome afterCampylobacter jejuniEnteritis

1 reference

12 December 2020

Exploring the complex relationships between infections and autoimmunity

1 reference

12 December 2020

Assessment: Neurologic risk of immunization: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Guillain-Barré syndrome and its relationship to swine influenza vaccination in Michigan, 1976-1977

1 reference

12 December 2020

Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine

1 reference

12 December 2020

A case-control study on children with Guillain-Barre syndrome in North China

1 reference

12 December 2020

Swine-influenza vaccination in multiple sclerosis

1 reference

12 December 2020

Haemophilus conjugate vaccine and Guillain-Barré syndrome.

1 reference

12 December 2020

Ganglioside mimicry as a cause of Guillain-Barré syndrome

1 reference

12 December 2020

Vaccines and Guillain-Barré syndrome

1 reference

12 December 2020

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008.

1 reference

12 December 2020

Global Advisory Committee on Vaccine Safety, 12-13 December 2007

1 reference

12 December 2020

Vaccination infection and autoimmunity: myth and reality VIAMR 2005-10-26-28, Beau-Rivage Palace Hotel, Lausanne, Switzerland

1 reference

12 December 2020

Risk of Guillain-Barré syndrome after measles-mumps-rubella vaccination

1 reference

12 December 2020

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008.

1 reference

12 December 2020

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States

1 reference

12 December 2020

Guillain-Barré syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine

1 reference

12 December 2020

Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology

1 reference

12 December 2020

Guillain-Barré syndrome after measles, mumps, and rubella vaccine

1 reference

12 December 2020

Serologic evidence of Campylobacter jejuni/coli enteritis in patients with Guillain-Barré syndrome

1 reference

12 December 2020

Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine

1 reference

12 December 2020

Influenza vaccine and the risk of relapse of Guillain-Barré syndrome

1 reference

12 December 2020

Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Differential expression of gangliosides on the surfaces of myelinated nerve fibers

1 reference

12 December 2020

Polyradiculoneuritis secondary to immunization with tetanus and diphtheria toxoids

1 reference

12 December 2020

Guillain-Barré syndrome after measles, mumps, and rubella vaccine

1 reference

12 December 2020

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006

1 reference

12 December 2020

Guillain-Barré syndrome following hepatitis B vaccination.

1 reference

12 December 2020

Temporal association between the isolation of Sabin-related poliovirus vaccine strains and the Guillain-Barré syndrome

1 reference

12 December 2020

Influenza vaccination and the Guillain-Barré syndrome

1 reference

12 December 2020

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008.

1 reference

12 December 2020

Surface potentials generated by synchronous activation of different fractions of the motor pool

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8213-3

7 January 2021

inferred from DOI database lookup

The New England Journal of Medicine

36

295

1204

LW Myers

1976

1 reference

DOI

https://api.crossref.org/works/10.1007/S12016-010-8213-3